Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP431816.RAjBArHWv8sia1qkYtYUVFPghQklqNPj7-3QAF6DuoirY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP431816.RAjBArHWv8sia1qkYtYUVFPghQklqNPj7-3QAF6DuoirY130_assertion type Assertion NP431816.RAjBArHWv8sia1qkYtYUVFPghQklqNPj7-3QAF6DuoirY130_head.
- NP431816.RAjBArHWv8sia1qkYtYUVFPghQklqNPj7-3QAF6DuoirY130_assertion wasGeneratedBy ECO_0000203 NP431816.RAjBArHWv8sia1qkYtYUVFPghQklqNPj7-3QAF6DuoirY130_provenance.
- NP431816.RAjBArHWv8sia1qkYtYUVFPghQklqNPj7-3QAF6DuoirY130_assertion wasDerivedFrom befree-2016 NP431816.RAjBArHWv8sia1qkYtYUVFPghQklqNPj7-3QAF6DuoirY130_provenance.
- NP431816.RAjBArHWv8sia1qkYtYUVFPghQklqNPj7-3QAF6DuoirY130_assertion SIO_000772 14965242 NP431816.RAjBArHWv8sia1qkYtYUVFPghQklqNPj7-3QAF6DuoirY130_provenance.
- NP431816.RAjBArHWv8sia1qkYtYUVFPghQklqNPj7-3QAF6DuoirY130_assertion evidence source_evidence_literature NP431816.RAjBArHWv8sia1qkYtYUVFPghQklqNPj7-3QAF6DuoirY130_provenance.
- NP431816.RAjBArHWv8sia1qkYtYUVFPghQklqNPj7-3QAF6DuoirY130_assertion description "[Clinical efficacy was first established in chemotherapy-induced emesis (and then in radiotherapy-induced and post-operative emesis), where 5-HT(3)-receptor antagonists set a new standard of antiemetic efficacy and tolerability.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP431816.RAjBArHWv8sia1qkYtYUVFPghQklqNPj7-3QAF6DuoirY130_provenance.